Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. - Yimer H; Melear J; Faber E; Bensinger WI; Burke JM; Narang M; Stevens D; Gunawardena S; Lutska Y; Qi K; Ukropec J; Qi M; et al. (British journal of haematology, 2019)